|
Agenix Limited - Company Profile Snapshot
| Company Profile: |
Agenix Limited |
| Ticker: |
AGXLY |
| Exchanges: |
JAK |
| 2008 Sales: |
65,987 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
AUSTRALIA |
| Employees: |
58 |
Business Description
Agenix Limited. The Group's principal activities are carried out through the following business segments: Monoclonal antibody development, which develops monoclonal antibody-based products; Molecular biology, which manufactures and sells biomedical products; and Agenix Biopharmaceuticals, which develops, manufactures and sells pharmaceutical products. Its core businesses are located in Australia with the manufacturing and distribution business segment having operations in the People's Republic of China. It maintains an office in Singapore and has certain operations in the United States of America.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
